Physician profile
Kimberly Kim
NPI 1790712115
$1,167.13
in general payments reported to CMS, 2019-2025
18 companies · $199 in 2025
The $199 reported for 2025 was more than what 83% of Pediatric Emergency Medicine (Pediatrics) providers received nationally (typical 2025 total: $53.43).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $103 · 2021: $121 · 2022: $245 · 2023: $199 · 2024: $157 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $416.90 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Sanofi Pasteur INC. | $123.74 | 2021-2025 | |
| Corium, LLC | $119.76 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $66.50 | 2019-2025 | Vaxneuvance, Gardasil 9, Proquad |
| Tris Pharma INC | $57.80 | 2020-2022 | |
| Ars Pharmaceuticals Operations, INC. | $56.93 | 2025 | Neffy |
| Kaleo, INC. | $55.41 | 2021-2022 | |
| Pfizer INC. | $48.07 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $42.34 | 2022-2023 | Flumist Quadrivalent |
| Ucb, INC. | $29.06 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.59 | 2025 | |
| Adlon Therapeutics L.P. | $23.52 | 2021 | |
| Ns Pharma, INC. | $23.32 | 2023 | Viltepso |
| Takeda Pharmaceuticals U.S.A., INC. | $22.40 | 2025 | Elaprase |
| Sobi, INC | $15.00 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $14.86 | 2022 | |
| Ironshore Pharmaceuticals INC. | $13.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.